about
5-Oxo-eicosatetraenoate is a broadly active, eosinophil-selective stimulus for human granulocytes5-Oxo-eicosanoids and hematopoietic cytokines cooperate in stimulating neutrophil function and the mitogen-activated protein kinase pathway.Conditioned media from human macrophages of M1 phenotype attenuate the cytotoxic effect of 5‑fluorouracil on the HT‑29 colon cancer cell line.Conditioned media from macrophages of M1, but not M2 phenotype, inhibit the proliferation of the colon cancer cell lines HT-29 and CACO-2.Multiple C-terminal serine phosphorylation accompanies both protein kinase C-dependent and -independent activation of cytosolic 85 kDa phospholipase A2 in macrophages.A glycerol ether induces mobilization and 12-lipoxygenation of arachidonic acid in macrophages. Synergistic effect on mobilization and induction of leukotriene C formation by activators of protein kinase CRegulation of arachidonate-mobilizing phospholipase A2 by phosphorylation via protein kinase C in macrophagesA phospholipase A2 hydrolyzing arachidonoyl-phospholipids in mouse peritoneal macrophagesProtein-mediated intermembrane contact specifically enhances Ca2+-induced fusion of phosphatidate-containing membranesProton-induced membrane fusion. Role of phospholipid composition and protein-mediated intermembrane contactRegulation of protein kinase B in rat adipocytes by insulin, vanadate, and peroxovanadate. Membrane translocation in response to peroxovanadatePhosphatidylinositol 3-kinase in zymosan- and bacteria-induced signalling to mobilisation of arachidonic acid in macrophagesInsulin-induced phosphorylation and activation of phosphodiesterase 3B in rat adipocytes: possible role for protein kinase B but not mitogen-activated protein kinase or p70 S6 kinaseInsulin-induced translocation of protein kinase B to the plasma membrane in rat adipocytes
P50
Q28283406-07DFB61D-18A8-48F1-9D9E-40A21B5669B5Q34384746-62DB8B2F-38AE-4763-A309-11EDEB0072DAQ38948535-930A4DBB-20A2-4BB7-968A-3DE9293A6FB7Q41885399-B7C3DAD7-2455-4352-96A4-F1565852189DQ42220998-EE667801-3737-4BAF-87AB-0E66C158999EQ67290671-CFD3A2B4-66FD-47AD-94E6-A62D79AC703DQ67554795-2BC05C68-2CC9-40EF-BE66-EB5786C76AF5Q69182222-C1010C9A-A08F-4FB0-B250-B2854112DC2DQ71731501-C43DEE53-5A00-4E64-B774-45D449EA55A4Q72396383-1BCAA735-02D4-427F-8B62-263DCFF66DAEQ73596296-587149D2-AB94-41ED-87F7-08D6F4A18EC8Q73835674-49F72213-DAE1-4785-9124-8D02F77689F8Q74013266-962A6DED-00E6-4263-A147-05D5181C1D9FQ74586040-746BD4E0-3BA5-4382-81E7-F79858F12B0D
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Jonny Wijkander
@ast
Jonny Wijkander
@en
Jonny Wijkander
@es
Jonny Wijkander
@nl
type
label
Jonny Wijkander
@ast
Jonny Wijkander
@en
Jonny Wijkander
@es
Jonny Wijkander
@nl
prefLabel
Jonny Wijkander
@ast
Jonny Wijkander
@en
Jonny Wijkander
@es
Jonny Wijkander
@nl
P106
P31
P496
0000-0002-2310-9039